OBJECTIVE: To assess the consistency between human papillomavirus (HPV) mRNA
testing in women with a history of previous HPV infections diagnosed by HPV DNA assay …

We read with interest the article by Cotton et al1 but disagree with their conclusion. Rather,
we believe that human papillomavirus (HPV) mRNA assays, when used in accord with US …

OBJECTIVE: To assess self-reported human papillomavirus (HPV) DNA testing practices by
health care providers and clinics, including nonrecommended practices such as low-risk …

Human papillomavirus (HPV) DNA testing was recently approved by the Food and Drug
Administration for use as an adjunct to cytology for cervical cancer screening. To help …

In 2009, the Cytopathology Education and Technology Consortium issued a statement on
human papillomavirus (HPV) DNA test utilization that was published in multiple journals. 1 …

Context.—Recent guidelines recommend colposcopy for women with atypical squamous
cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H). Objective.—To …

OBJECTIVE: The objective of the study was to describe baseline data from Addressing the
Need for Advanced HPV Diagnostics, a prospective, multicenter US cervical cancer …

BACKGROUND High‐risk human papillomavirus (HR‐HPV) testing has been proposed as a
replacement for cytology or as an adjunct to cytology for primary cervical carcinoma …

Integrating human papillomavirus (HPV) testing into the practice of cervical cancer
screening is a continuous process that begins and ends with education. An understanding of …

Although PCR analysis is a sensitive test for detection of human papillomavirus (HPV) in the
cervix, the proportion of cases of cervical dysplasia missed, or the false-negative rate, has …